Filing Details
- Accession Number:
- 0001209191-17-045945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 16:20:40
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 16:20:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649245 | G. Phillip Febbo | 301 Penobscot Dr. Redwood City CA 94063 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-07-19 | 2,844 | $33.57 | 18,130 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-19 | 330 | $33.57 | 17,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017.
- Represents weighted average sale price. Actual sale prices ranged from $33.31 to $33.80.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents actual sale price.
Billionaire Hedge Funds
